HU9300349D0 - Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them - Google Patents

Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them

Info

Publication number
HU9300349D0
HU9300349D0 HU93349A HU9300349A HU9300349D0 HU 9300349 D0 HU9300349 D0 HU 9300349D0 HU 93349 A HU93349 A HU 93349A HU 9300349 A HU9300349 A HU 9300349A HU 9300349 D0 HU9300349 D0 HU 9300349D0
Authority
HU
Hungary
Prior art keywords
derivatives
contqining
piperidylidene
cyclohepta
pyrido
Prior art date
Application number
HU93349A
Other languages
English (en)
Other versions
HUT64238A (en
Inventor
Hans Loibner
Original Assignee
Sandoz Ag
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag, Sandoz Ltd filed Critical Sandoz Ag
Publication of HU9300349D0 publication Critical patent/HU9300349D0/hu
Publication of HUT64238A publication Critical patent/HUT64238A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
HU9300349A 1990-08-11 1991-08-08 Method for producing of medical products containing monoclonal antibody br 55-2 or fragments thereof HUT64238A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (2)

Publication Number Publication Date
HU9300349D0 true HU9300349D0 (en) 1993-05-28
HUT64238A HUT64238A (en) 1993-12-28

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9300349A HUT64238A (en) 1990-08-11 1991-08-08 Method for producing of medical products containing monoclonal antibody br 55-2 or fragments thereof

Country Status (13)

Country Link
EP (1) EP0547079B1 (hu)
JP (1) JPH06500771A (hu)
KR (1) KR930701193A (hu)
AT (1) ATE136469T1 (hu)
AU (1) AU657489B2 (hu)
CA (1) CA2088370C (hu)
DE (2) DE4025499A1 (hu)
HU (1) HUT64238A (hu)
IE (1) IE912823A1 (hu)
PT (1) PT98622A (hu)
TW (1) TW223019B (hu)
WO (1) WO1992003165A1 (hu)
ZA (1) ZA916313B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0528767B1 (en) * 1991-08-21 2000-01-12 Novartis AG Antibody derivatives
KR100279317B1 (ko) * 1992-05-22 2001-01-15 더블류. 하링, 지. 보이롤 단일클론항체
JP2002519334A (ja) * 1998-06-29 2002-07-02 ベルクター，ヴォルフガンク αエミッタとβエミッタとを主成分とする抗ウイルスおよび抗レトロウイルス放射免疫薬剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (en) * 1985-11-25 1987-06-04 Quash Gerard A Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
ATE136469T1 (de) 1996-04-15
HUT64238A (en) 1993-12-28
AU8393291A (en) 1992-03-17
CA2088370C (en) 2003-03-25
AU657489B2 (en) 1995-03-16
IE912823A1 (en) 1992-02-12
DE69118702D1 (de) 1996-05-15
DE4025499A1 (de) 1992-02-13
PT98622A (pt) 1992-06-30
JPH06500771A (ja) 1994-01-27
EP0547079B1 (en) 1996-04-10
EP0547079A1 (en) 1993-06-23
KR930701193A (ko) 1993-06-11
DE69118702T2 (de) 1996-09-05
ZA916313B (en) 1993-04-28
CA2088370A1 (en) 1992-02-12
TW223019B (hu) 1994-05-01
WO1992003165A1 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
ATE104348T1 (de) O-glycosyliertes ifn-alpha.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
HUT46062A (en) Process for producing human monoclonal antibody compositions protecting from bacterial infections and pharmaceutics comprising the same
ATE151078T1 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
MX9101958A (es) Inhibidores de acat de urea de aminosulfonilo
EP0325129A3 (en) Disubstituted pyridines
ITBO930061A0 (it) Metodo e macchina per la realizzazione di pacchetti doppi di sigaret- te.
FR2707994B1 (fr) Composites moléculaires de siloxane, procédé de préparation desdits composites, et leurs utilisations.
AU2192588A (en) Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production
HU9300349D0 (en) Method for producing dibenzo- or benzo-pyrido-cyclohepta-piperidine derivatives or piperidylidene or piperazine derivatives thereof as well as pharmaceutical preparatives contqining them
AU3018289A (en) Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions, and vaccine
AU2484488A (en) Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto
BG100779A (en) Derivatives of 12.13-epoxytylosin and methods for their preparation
FR2708610B1 (fr) Dérivés du carboxyméthylidènecycloheptimidazole, méthode pour leur fabrication et agents thérapeutiques les contenant.
DE69012034D1 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
FR2608926B1 (fr) Antigene de babesia divergens, procede pour le produire et vaccin le contenant
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
IT8820855A0 (it) Procedimento migliorato per laproduzione di doxorubicina ederivati relativi.
DE59505934D1 (de) Vitamin b 12-haltige sanddornkonzentrate oder -extrakte
PL322847A1 (en) Condensed b-carbolins
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee